신경과홍근식 교수

전문분야
뇌졸중, 어지럼증, 두통
진료일정
진료일정표
날짜 9(월) 10(화) 11(수) 12(목) 13(금) 14(토)
오전
오후
외래
외래
외래
외래
휴진일정
  • 2019.12.14(토) ~ 2019.12.18(수) : 휴가
진료예약
TAG
  • #뇌졸중
  • #두통
  • #어지럼증

경력

  • 1991년 서울의대 졸업
  • 1992년 서울대병원 인턴 수료
  • 1996년 서울대병원 신경과 전공의 수료
  • 1996년 신경과 전문의 취득
  • 2000년 서울대병원 신경과 전임의 수료
  • 2000-현재 인제대학교 일산백병원 신경과
  • 전임강사, 조교수, 부교수, 교수
  • 2000.3.-2008.3. 인제대학교 일산백병원 신경과 주임교수
  • 2008.9-2010.2 ULCA 뇌졸중센터 방문교수

주요활동

  • 신경과 전문의
  • 대한뇌졸중학회 홍보이사
  • 1. 2011 경기도 의사회 참의료인상 학술부문 수상
  • 2. 2011. 5월 Biological Research Information Center (BRIC) in Korea (http://bric.postech.ac.kr) 에 한국을 빛낸 사람에 등재
  • 3. 2012.1. 인제대학교 인제학술상 수상

  • Professional Activities
  • Director, Guideline Development Committee, Korean Stroke Society: 2018.3.-
  • Director, Scientific Committee, Korean Stroke Society: 2016.3. 2018.2
  • Director, Public Relationship Committee, Korean Neurological Association: 2016.3. ? 2018.2.
  • Director, Public Relationship Committee, Korean Stroke Society: 2004 - 2008, 2010 - 2016
  • Member, Korean Stroke Society, 1997 present
  • Member, Korean Neurological Association, 1992 present
  • Member of World Stroke Organization, 2014 present
  • Director, Korean Stroke Guidelines Development Task Force, 2006 2015
  • Director, Primary Stroke Prevention Guideline Writing Committee, Korean Stroke Guidelines Development Group, 2006 2015
  • Member, Advisory Committee for Cardiovascular Disease Prevention Program, Korea Centers for Disease Control and Prevention, 2006-2015
  • Member, Scientific Committee, Korean Neurological Association, 2014-2015
  • Member, Steering Committee, Ilsan Paik Hospital, Inje University, 2010-2014
  • Member, Practice Evaluation Committee, Ilsan Paik Hospital, Inje University, 2013-2014
  • Member, Ethics Committee, Ilsan Paik Hospital, Inje University, 2011-2014
  • Member, Clinical Research Center Committee, Ilsan Paik Hospital, Inje University, 2010-2013
  • Member, Drug Committee, Ilsan Paik Hospital, Inje University, 2004-2008
  • Member, ICU Operating Committee, Ilsan Paik Hospital, Inje University, 2004-2006
  • Member, Brain Death Evaluation Committee, Ilsan Paik Hospital, Inje University, 2002-2014
  • Member, Nutrition Evaluation Committee, Ilsan Paik Hospital, Inje University, 2002-2006
  • Member, Education and Training Committee, Ilsan Paik Hospital, Inje University, 2002-2007
  • Director, External Collaboration Committee, Ilsan Paik Hospital, Inje University, 2010-2014

  • Editorships and Journal Referee
  • Associate Editor, Journal of Stroke, 2016 - present
  • Editorial Board and Reviewer, Journal of Stroke, 2013 - present
  • Reviewer, Stroke, 2010 - present
  • Reviewer, International Journal of Stroke, 2011 - present
  • Reviewer, Journal of Neurological Sciences, 2014 - present
  • Reviewer, Cerebrovascular Diseases, 2013 - present
  • Reviewer, Journal of Neurological Sciences, 2014 - present
  • Reviewer, Journal of Clinical Neurology, 2005 - present
  • Reviewer, Journal of Korean Neurological Association, 2004 - present
  • Reviewer, Korean Journal of Stroke, 2005 - present
  • Reviewer, Journal of Korean Medical Science, 2002, 2007

  • Honors and Awards
  • Award for the contribution to the Journal of Stroke from the Korean Stroke Society, May 2015
  • Distinguished Scholar Award from Ilsan Paik Hospital, June 2015
  • Distinguished Scholar Award from Gyeonggi Province Medical Association, Aug 2011
  • Listed in Distinguished Scholars in the Biological Research Information Center (BRIC) of Korea (http://bric.postech.ac.kr/) for his outstanding academic article, May 2011
  • Award for Distinguished Topic Presentation from the Korean Stroke Society, May 2010
  • Distinguished Scholar Award from Inje University, Jan 2012
  • Distinguished Scholar Award from Ilsan Paik Hospital, Jun 2010
  • Distinguished Scholar Award from Ilsan Paik Hospital, Jun 2012
  • Distinguished Scholar Award from Ilsan Paik Hospital, Jun 2005
  • Award for the Code Stroke Program Implementation from Ilsan Paik Hospital, Jan 2008
  • Award for the Code Stroke Program Implementation from Inje University, Mar 2008
  • Award for the contribution to National Cardiovascular Disease Prevention Education Program from Korea Centers for Disease Control and Prevention, Mar 2012
  • Award for the contribution to National Healthcare Program from Ministry of Health & Welfare of Korea, Mar 2012

연구업적

  • Publications and Citations
  • Publications
  • As a first or corresponding author in international journals: 42 articles (as of Mar 2018)
  • 1.Association of Systolic Blood Pressure with Progression of Symptomatic Intracranial Atherosclerotic Stenosis. Park JH, Ovbiagele B, Hong KS, Kwon SU. J Stroke. 2017 Sep;19(3):304-311
  • 2.Rivaroxaban vs Warfarin Sodium in the Ultra-Early Period After Atrial Fibrillation-Related Mild Ischemic Stroke: A Randomized Clinical Trial. Hong KS, Kwon SU, Lee SH, Lee JS, Kim YJ, Song TJ, Kim YD, Park MS, Kim EG, Cha JK, Sung SM, Yoon BW, Bang OY, Seo WK, Hwang YH, Ahn SH, Kang DW, Kang HG, Yu KH; Phase 2 Exploratory Clinical Study to Assess the Effects of Xarelto (Rivaroxaban) Versus Warfarin on Ischemia, Bleeding, and Hospital Stay in Acute Cerebral Infarction Patients With Non-valvular Atrial Fibrillation (Triple AXEL) Study Group. JAMA Neurol. 2017 Oct 1;74(10):1206-1215
  • 3. Quality of Anticoagulation with Warfarin in Korean Patients with Atrial Fibrillation and Prior Stroke: A Multicenter Retrospective Observational Study. Hong KS, Kim YK, Bae HJ, Nam HS, Kwon SU, Bang OY, Cha JK, Yoon BW, Rha JH, Lee BC, Park JM, Park MS, Lee J, Choi JC, Kim DE, Lee KB, Park TH, Lee JS, Kim SE, Lee J. J Clin Neurol. 2017 Jul;13(3):273-280.
  • 4. Blood Pressure Management for Stroke Prevention and in Acute Stroke. Hong KS. J Stroke. 2017 May;19(2):152-165.
  • 5. Endovascular Therapy: The Second Round Begins.Lee JS, Hong KS. J Stroke. 2017 May;19(2):119-120.
  • 6. Simple estimates using age and stroke severity for intracranial hemorrhage and outcome after intravenous thrombolysis. Hye Jung Lee, Ji Sung Lee, Jay Chol Choi, Yong-Jin Cho, Beom Joon Kim, Hee-Joon Bae, Dong-Eog Kim, Wi-Sun Ryu, Jae-Kwan Cha, Dae Hyun Kim, Hyun-Wook Nah, Kang-Ho Choi, Joon-Tae Kim, Man-Seok Park, Jeong-Ho Hong, Sung Il Sohn, Kyusik Kang, Jong-Moo Park, Wook-Joo Kim, Jun Lee, Dong-Ick Shin, Min-Ju Yeo, Kyung Bok Lee, Jae Guk Kim, Soo Joo Lee, Byung-Chul Lee, Mi Sun Oh, Kyung-Ho Yu, Tai Hwan Park, Juneyoung Lee, Keun-Sik Hong. J Stroke 2017 In press
  • 7. Prestroke Antiplatelet Effect on Symptomatic Intracranial Hemorrhage and Functional Outcome in Intravenous Thrombolysis. Choi JC, Lee JS, Park TH, Cho YJ, Park JM, Kang K, Lee KB, Lee SJ, Kim JG, Lee J, Park MS, Choi KH, Kim JT, Yu KH, Lee BC, Oh MS, Cha JK, Kim DH, Nah HW, Kim DE, Ryu WS, Kim BJ, Bae HJ, Kim WJ, Shin DI, Yeo MJ, Sohn SI, Hong JH, Lee J, Hong KS. J Stroke. 2016 Sep;18(3):344-351.
  • 8. Recurrent Ischemic Lesions after Acute Atherothrombotic Stroke: Clopidogrel plus Aspirin vs. Aspirin alone. Keun-Sik Hong, Seung-Hoon Lee, Eung Gyu Kim, Ki-Hyun Cho, Dae Il Chang, Joung-Ho Rha, Hee-Joon Bae, Kyung Bok Lee, Dong Eog Kim, Jong-Moo Park, Hahn-Young Kim, Jae-Kwan Cha, Kyung-Ho Yu, Yong-Seok Lee, Soo Joo Lee, Jay Chol Choi, Yong-Jin Cho, Sun U. Kwon, Gyeong-Moon Kim, Sung-Il Sohn, Kwang-Yeol Park, Dong-Wha Kang, Chul-Ho Sohn, Jun Lee, Byung-Woo Yoon. Stroke 2016 Sep;47(9):2323-30
  • 9. Update of the Korean Clinical Practice Guidelines for Endovascular Recanalization Therapy in Patients with Acute Ischemic Stroke. Keun-Sik Hong, Sang-Bae Ko, Kyung-Ho Yu, Cheolkyu Jung, Sukh Que Park, Byung Moon Kim, Chul-Hoon Chang, Hee-Joon Bae, Ji Hoe Heo, Chang Wan Oh, Byung-Chul Lee, Bum-Tae Kim, Bum-soo Kim, Chin-Sang Chung, Byung-Woo Yoon, Joung-Ho Rha. J Stroke. 2016;18(1):102-113.
  • 10. Recurrent Stroke, Myocardial Infarction, and Major Vascular Events during the First Year after Acute Ischemic Stroke: The Multicenter Prospective Observational Study about Recurrence and Its Determinants after Acute Ischemic Stroke I. Kang K, Park TH, Kim N, Jang MU, Park SS, Park JM, Ko Y, Lee S, Lee KB, Lee J, Kim DE, Cho YJ, Kim JT, Kim DH, Cha JK, Han MK, Lee JS, Lee J, Oh MS, Choi JC, Lee BC, Hong KS, Bae HJ. J Stroke Cerebrovasc Dis.
  • 11. Rationale and Design of PreventIon of Cardiovascular events in iSchemic Stroke patients with high risk of cerebral hemorrhage (PICASSO) study; a randomized controlled trial. Hong KS, BJ Kim, J Lee, SU Kwon. Int J Stroke 2015;10:1153-8.
  • 12. Effect of pre-stroke statin use on stroke severity and early functional recovery: a retrospective cohort study. JC Choi, JS Lee, TH Park, YJ Cho, JM Park, K Kang, KB Lee, SJ Lee, Y Ko, J Lee, JT Kim, KH Yu, BC Lee, JK Cha, DH Kim, J Lee, DE Kim, MS Jang, BJ Kim, MK Han, HJ Bae, KS Hong. BMC Neurol. 2015 Jul 30;15:120. doi: 10.1186/s12883-015-0376-3.
  • 13. Intravenous tissue plasminogen activator improves the outcome in very elderly Korean patients with acute ischemic stroke. JC Choi, JS Lee, TH Park, SS Park, YJ Cho, JM Park, K Kang, KB Lee, SJ Lee, Y Ko, JG Kim, J Lee, KH Cho, JT Kim, KH Yu, BC Lee, MS Oh, JK Cha, DH Kim, HW Nah, DE Kim, WS Ryu, BJ Kim, HJ Bae, WJ Kim, DI Shin, MJ Yeo, SI Sohn, JH Hong, J Lee, KS Hong. J Stroke 2015;17(3):327-335.
  • 14. Dabigatran effect on left ventricular thrombus in a patient with acute ischemic stroke. K Chung, YM Paek, HJ Lee, KS Hong. J Stroke 2015;17(3):366-368.
  • 15. Statins in Acute Ischemic Stroke: Systematic Review. Hong KS, JS Lee. J Stroke 2015;17(3):282-301.
  • 16. Endovascular Recanalization Therapy in Acute Ischemic Stroke: Updated Meta-analysis of Randomized Controlled Trials. Keun-Sik Hong, Sang-Bae Ko, Ji Sung Lee, Kyung-Ho Yu, Joung-Ho Rha. J Stroke 2015;17(3):268-81.
  • 17. Rationale and design of Triple AXEL: trial for early anticoagulation in acute ischemic stroke patients with nonvalvular atrial fibrillation. Hong KS, Choi YJ, Kwon SU; Triple AXEL Investigators. Int J Stroke. 2015 Jan;10(1):128-33.
  • 18. Trends in yield of a code stroke program for enhancing thrombolysis. Kim A, Lee JS, Kim JE, Paek YM, Chung K, Park JH, Cho YJ, Hong KS. J Clin Neurosci. 2015;22(1):73-8.
  • 19. Dual Antiplatelet Therapy after Noncardioembolic Ischemic Stroke or Transient Ischemic Attack: Pros and Cons. Keun-Sik Hong. J Clin Neurol. 2014;10(3);189-196.
  • 20. Safety and Efficacy of Intravenous Recombinant Tissue Plasminogen Activator Administered in the 3- to 4.5-hour Window in Korea. Tai Hwan Park, Ji Sung Lee, Sang-Soon Park, Youngchai Ko, Soo Joo Lee, Kyung Bok Lee, Jun Lee, Kyusik Kang, Jong-Moo Park, Jay Chol Choi, Dong-Eog Kim, Yong-Jin Cho, Joon-Tae Kim, Dae-Hyun Kim, Jae-Kwan Cha, Moon-Ku Han, Juneyoung Lee, Mi Sun Oh, Kyung-Ho Yu, Byung-Chul Lee, Hee-Joon Bae, Keun-Sik Hong. J Stroke Cerebrovasc Dis. 2014 Aug;23(7):1805-12.
  • 21. Disability weight for each level of the Expanded Disability Status Scale in multiple sclerosis. Cho JY, Hong KS, Kim HJ, Kim SH, Min JH, Kim NH, Ahn SW, Park MS, An JY, Kim BJ, Kim W. Mult Scler. 2014;20(9):1217-1223.
  • 22. Statin Preion Adhered to Guidelines for Patients Hospitalized due to Acute Ischemic Stroke or Transient Ischemic Attack. Hong KS, Oh MS, Choi HY, Cho AH, Kwon HM, Yu KH, Bae HJ, Lee J, Lee BC; ROLLERKOST Study Group. J Clin Neurol. 2013 Oct;9(4):214-22.
  • 23. Greater stroke severity predominates over all other factors for the worse outcome of cardioembolic stroke. Keun-Sik Hong, Juneyoung Lee, Hee-Joon Bae, Ji Sung Lee, Dong-Wha Kang, Kyung-Ho Yu, Moon-Ku Han, Yong-Jin Cho, Pamela Song, Jong-Moo Park, Mi-Sun Oh, Jaseong Koo, Byung-Chul Lee. J Stroke Cerebrovasc Dis. 2013 Nov;22(8):e373-80.
  • 24. Validation of Minor Stroke Definitions for Thrombolysis Decision Making. Tai Hwan Park, Keun-Sik Hong, Jay Chol Choi, Pamela Song, Ji Sung Lee, Juneyoung Lee, Jong-Moo Park, Kyusik Kang, Kyung Bok Lee, Yong-Jin Cho, Gustavo Saposnik, Moon-Ku Han, Hee-Joon Bae. Journal of Stroke & Cerebrovascular Diseases. 2013: 22 (4): 482-490.
  • 25. Stroke Statistics in Korea: Part II Stroke Awareness and Acute Stroke Care, A Report from the Korean Stroke Society and Clinical Research Center for Stroke. Keun-Sik Hong, Oh Young Bang, Jong S. Kim, Ji Hoe Heo, Kyung-Ho Yu, Hee-Joon Bae, Dong-Wha Kang, Jin Soo Lee, Sun U. Kwon, Chang Wan Oh, Byung-Chul Lee, Byung-Woo Yoon. Journal of Stroke. 2013;15:67-77.
  • 26. Stroke Statistics in Korea: Part I. Epidemiology and Risk Factors: A Report from the Korean Stroke Society and Clinical Research Center for Stroke. Keun-Sik Hong, Oh Young Bang, Dong-Wha Kang, Kyung-Ho Yu, Hee-Joon Bae, Jin Soo Lee, Ji Hoe Heo, Sun U. Kwon, Chang Wan Oh, Byung-Chul Lee, Jong S. Kim, Byung-Woo Yoon. Journal of Stroke. 2013;15:2-20.
  • 27. Efficacy and safety of thrombolysis in patients aged 80 years or above with major acute ischemic stroke. Kim SC, Hong KS, Cho YJ, Cho JY, Park HK, Song P. Neurol India. 2012 Jul-Aug;60(4):373-8.
  • 28. Safety and efficacy of mechanical thrombectomy with the Solitaire device in large artery occlusion. Kim JE, Kim AR, Paek YM, Cho YJ, Lee BH, Hong KS. Neurol India. 2012 Jul-Aug;60(4):400-5.
  • 29. Declining Stroke and Vascular Event Recurrence Rates in Secondary Prevention Trials over the Past 50 Years and Consequences for Current Trial Design. Hong KS, Yegiaian S, Lee M, Lee J, Saver JL. Circulation 2011;123:2111-2119.
  • 30. Weighting Components of Composite Endpoints in Clinical Trials: An Approach Employing Disability Adjusted Life Years. Hong KS, Ali K, Selco SL, Fonarow GC, Saver JL. Stroke 2011;42:1722-9.
  • 31. Disability-Adjusted Life Years (DALY) analysis: Implications for stroke research. Hong KS. J Clin Neurol. 2011:7;109-114.
  • 32. Burden of Ischemic Stroke in Korea: Disability-Adjusted Life Years (DALY) lost Analysis. Hong KS, Kim J, Cho YJ, Seo SY, Hwang SI, Kim SC, Kim JE, Cho JY, Park HK, Bae HJ, Yang MH, Jang MS, Han MK, Lee J, Kang DW, Park JM, Koo J, Yu KH, Oh MS, Lee BC. J Clin Neurol. 2011;7:77-84.
  • 33. Years of Optimum Health Lost Due to Complications After Acute Ischemic Stroke. Disability-Adjusted Life-Years Analysis. Hong KS, Saver JL, Kang DW, Bae HJ, Yu KH, Koo J, Han MK, Cho YJ, Park JM, Lee BC. Stroke. 2010 Aug;41(8):1758-65.
  • 34. Years of disability-adjusted life gained as a result of thrombolytic therapy for acute ischemic stroke. Hong KS, Saver JL. Stroke. 2010 Mar;41(3):471-7.
  • 35. Effect of cilnidipine vs losartan on cerebral blood flow in hypertensive patients with a history of ischemic stroke: a randomized controlled trial. Hong KS, Kang DW, Bae HJ, Kim YK, Han MK, Park JM, Rha JH, Lee YS, Koo JS, Cho YJ, Kwon SU, Kim SE, Park SH. Acta Neurol Scand. 2010 Jan;121(1):51-7.
  • 36. Quantifying the value of stroke disability outcomes: WHO global burden of disease project disability weights for each level of the modified Rankin Scale. Hong KS, Saver JL. Stroke. 2009 Dec;40(12):3828-33.
  • 37. Intravenous recombinant tissue plasminogen activator thrombolysis in a patient with acute ischemic stroke secondary to aortic dissection. Hong KS, Park SY, Whang SI, Seo SY, Lee DH, Kim HJ, Cho JY, Cho YJ, Jang WI, Kim CY. J Clin Neurol. 2009 Mar;5(1):49-52.
  • 38. Impact of neurological and medical complications on 3-month outcomes in acute ischaemic stroke. Hong KS, Kang DW, Koo JS, Yu KH, Han MK, Cho YJ, Park JM, Bae HJ, Lee BC. Eur J Neurol. 2008 Dec;15(12):1324-31.
  • 39. Diffusion changes suggesting vasogenic edema during partial status epilepticus. Keun-Sik Hong, Yong-Jin Cho, Sang Kun Lee, Sang-Wuk Jeong, Kwon-kyoo Kim, Eun-Jin Oh. Seizure 2004:13;317-321.
  • 40. Pre-surgical uation and surgical outcome of 41 patients with non-lesional neocortical epilepsy. Keun-Sik Hong, Sang Kun Lee, Joo-Yong Kim, Dong-Soo Lee, Chun-kee Chung. Seizure 2002;11:184-192.
  • 41. Diffusion-weighted magnetic resonance imaging in Wernicke's encephalopathy. Keun-Sik Hong, Dong-Wha Kang, Yong-Jin Cho, Yoon-Joon Hwang, Gham Hur. Acta Neurol Scand 2002:105;132-134.
  • 42. Visual working memory revealed by repetitive transcranial magnetic stimulation. Keun-Sik Hong, Sang Kun Lee, Joo-Yong Kim, Kwang-Ki Kim, Hyunwoo Nam. Journal of the Neurological Sciences 2000;181:50-55.

  • As a Co-author in international journals: 89 articles (as of Mar 2018)
  • 1. Posttreatment National Institutes of Health Stroke Scale Is Superior to the Initial Score or Thrombolysis in Cerebral Ischemia for 3-Month Outcome. Jeong HG, Kim BJ, Choi JC, Hong KS, Yang MH, Jung C, Han MK, Bae HJ. Stroke. 2018 Mar 13.
  • 2. Intracranial Aneurysm Is Associated with High Intracranial Artery Tortuosity. Kim BJ, Lee SH, Kwun BD, Kang HG, Hong KS, Kang DW, Kim JS, Kwon SU. World Neurosurg. 2018 Feb 7.
  • 3. Folic Acid in Stroke Prevention in Countries without Mandatory Folic Acid Food Fortification: A Meta-Analysis of Randomized Controlled Trials. Hsu CY, Chiu SW, Hong KS, Saver JL, Wu YL, Lee JD, Lee M, Ovbiagele B. J Stroke. 2018 Jan;20(1):99-109.
  • 4. Endovascular Thrombectomy for Ischemic Stroke Increases Disability-Free Survival, Quality of Life, and Life Expectancy and Reduces Cost. Campbell BCV, Mitchell PJ, Churilov L, Keshtkaran M, Hong KS, Kleinig TJ, Dewey HM, Yassi N, Yan B, Dowling RJ, Parsons MW, Wu TY, Brooks M, Simpson MA, Miteff F, Levi CR, Krause M, Harrington TJ, Faulder KC, Steinfort BS, Ang T, Scroop R, Barber PA, McGuinness B, Wijeratne T, Phan TG, Chong W, Chandra RV, Bladin CF, Rice H, de Villiers L, Ma H, Desmond PM, Meretoja A, Cadilhac DA, Donnan GA, Davis SM; EXTEND-IA Investigators. Front Neurol. 2017 Dec 14;8:657.
  • 5. Predictive Value of Pulse Pressure in Acute Ischemic Stroke for Future Major Vascular Events. Lee KJ, Kim BJ, Han MK, Kim JT, Cho KH, Shin DI, Yeo MJ, Cha JK, Kim DH, Nah HW, Kim DE, Ryu WS, Park JM, Kang K, Lee SJ, Oh MS, Yu KH, Lee BC, Hong KS, Cho YJ, Choi JC, Sohn SI, Hong JH, Park TH, Park SS, Kwon JH, Kim WJ, Lee J, Lee JS, Lee J, Gorelick PB, Bae HJ; CRCS-5 Investigators. Stroke. 2018 Jan;49(1):46-53.
  • 6. One-Year Outcomes After Minor Stroke or High-Risk Transient Ischemic Attack: Korean Multicenter Stroke Registry Analysis. Park HK, Kim BJ, Han MK, Park JM, Kang K, Lee SJ, Kim JG, Cha JK, Kim DH, Nah HW, Park TH, Park SS, Lee KB, Lee J, Hong KS, Cho YJ, Lee BC, Yu KH, Oh MS, Kim JT, Choi KH, Kim DE, Ryu WS, Choi JC, Johansson S, Lee SJ, Lee WH, Lee JS, Lee J, Bae HJ. Stroke. 2017 Oct 3.
  • 7. Antiplatelet Regimen for Patients With Breakthrough Strokes While on Aspirin: A Systematic Review and Meta-Analysis. Lee M, Saver JL, Hong KS, Rao NM, Wu YL, Ovbiagele B. Stroke. 2017 Sep;48(9):2610-2613.
  • 8. Preceding Intravenous Thrombolysis in Patients Receiving Endovascular Therapy. Park HK, Chung JW, Hong JH, Jang MU, Noh HD, Park JM, Kang K, Lee SJ, Ko Y, Kim JG, Cha JK, Kim DH, Nah HW, Han MK, Kim BJ, Park TH, Park SS, Lee KB, Lee J, Hong KS, Cho YJ, Lee BC, Yu KH, Oh MS, Cho KH, Kim JT, Kim DE, Ryu WS, Choi JC, Kim WJ, Shin DI, Yeo MJ, Sohn SI, Lee JS, Lee J, Yoon BW, Bae HJ. Cerebrovasc Dis. 2017;44(1-2):51-58.
  • 9. Utility of Items of Baseline National Institutes of Health Stroke Scale as Predictors of Functional Outcomes at Three Months after Mild Ischemic Stroke. Choi JC, Kim BJ, Han MK, Lee SJ, Kang K, Park JM, Park SS, Park TH, Cho YJ, Hong KS, Lee KB, Lee J, Ryu WS, Kim DE, Nah HW, Kim DH, Cha JK, Kim JT, Choi KH, Oh MS, Yu KH, Lee BC, Jang MS, Lee JS, Lee J, Bae HJ; CRCS-5 Investigators. J Stroke Cerebrovasc Dis. 2017 Jun;26(6):1306-1313.
  • 10. Stroke outcomes are worse with larger leukoaraiosis volumes. Ryu WS, Woo SH, Schellingerhout D, Jang MU, Park KJ, Hong KS, Jeong SW, Na JY, Cho KH, Kim JT, Kim BJ, Han MK, Lee J, Cha JK, Kim DH, Lee SJ, Ko Y, Cho YJ, Lee BC, Yu KH, Oh MS, Park JM, Kang K, Lee KB, Park TH, Lee J, Choi HK, Lee K, Bae HJ, Kim DE. Brain. 2017 Jan;140(Pt 1):158-170
  • 11. Clinical Outcomes of Posterior Versus Anterior Circulation Infarction With Low National Institutes of Health Stroke Scale Scores. Kim JT, Park MS, Choi KH, Kim BJ, Han MK, Park TH, Park SS, Lee KB, Lee BC, Yu KH, Oh MS, Cha JK, Kim DH, Nah HW, Lee J, Lee SJ, Ko Y, Kim JG, Park JM, Kang K, Cho YJ, Hong KS, Choi JC, Kim DE, Ryu WS, Shin DI, Yeo MJ, Kim WJ, Lee J, Lee JS, Bae HJ, Saver JL, Cho KH. Stroke. 2016 Nov 17. pii: STROKEAHA.116.013432. [Epub ahead of print]
  • 12. Air Pollution Is Associated With Ischemic Stroke via Cardiogenic Embolism. Chung JW, Bang OY, Ahn K, Park SS, Park TH, Kim JG, Ko Y, Lee S, Lee KB, Lee J, Kang K, Park JM, Cho YJ, Hong KS, Nah HW, Kim DH, Cha JK, Ryu WS, Kim DE, Kim JT, Choi JC, Oh MS, Yu KH, Lee BC, Lee JS, Lee J, Park HK, Kim BJ, Han MK, Bae HJ. Stroke 2016 In press
  • 13. Characteristics of the Drip-and-Ship Paradigm for Patients with Acute Ischemic Stroke in South Korea. Park MS, Lee JS, Park TH, Cho YJ, Hong KS, Park JM, Kang K, Lee KB, Kim JG, Lee SJ, Lee J, Choi KH, Kim JT, Cho KH, Oh MS, Yu KH, Lee BC, Cha JK, Kim DH, Nah HW, Lee J, Kim DE, Ryu WS, Kim BJ, Han MK, Bae HJ, Song SK, Choi JC. J Stroke Cerebrovasc Dis. 2016;25(11): 2678?2687
  • 14. Family History and Risk of Recurrent Stroke. Chung JW, Kim BJ, Han MK, Kang K, Park JM, Park SS, Park TH, Cho YJ, Hong KS, Lee KB, Kim JG, Ko Y, Lee S, Nah HW, Kim DH, Cha JK, Oh MS, Yu KH, Lee BC, Jang MS, Lee JS, Lee J, Bae HJ; CRCS-5 Investigators. Stroke. 2016 Aug;47(8):1990-6.
  • 15. Endovascular Treatment in Patients with Persistent Internal Carotid Artery Occlusion after Intravenous Tissue Plasminogen Activator: A Clinical Effectiveness Study. Hong JH, Sohn SI, Kang J, Jang MU, Kim BJ, Han MK, Park TH, Park SS, Lee KB, Lee BC, Yu KH, Oh MS, Cha JK, Kim DH, Lee J, Lee SJ, Ko Y, Kim JG, Park JM, Kang K, Cho YJ, Hong KS, Cho KH, Kim JT, Choi JC, Lee J, Lee JS, Gorelick PB, Bae HJ. Cerebrovasc Dis. 2016 Jul 1;42(5-6):387-394
  • 16. Design and Rationale for a Cognitive Outcome Substudy in Ischemic Stroke Patients with High Risk of Cerebral Hemorrhage. Yu KH, Hong KS, Oh MS, Lee J, Lee JS, Kwon SU; PICASSO investigators. J Stroke Cerebrovasc Dis. 2016
  • 17. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis? Lee SH, Kim BJ, Han MK, Park TH, Lee KB, Lee BC, Yu KH, Oh MS, Cha JK, Kim DH, Nah HW, Lee J, Lee SJ, Ko Y, Kim JG, Park JM, Kang K, Cho YJ, Hong KS, Choi JC, Kim JT, Choi K, Kim DE, Ryu WS, Kim WJ, Shin DI, Yeo M, Lee J, Lee JS, Gorelick PB, Bae HJ. Int J Stroke 2016
  • 18. Asian Patients with Stroke plus Atrial Fibrillation and the Dose of Non-vitamin K Oral Anticoagulants. Bang OY, Hong KS, Heo JH. J Stroke. 2016;18(2):169-78
  • 19. Impact of Guidelines on Clinical Practice: Intravenous Heparin Use for Acute Ischemic Stroke. Chung JW, Kim BJ, Han MK, Ko Y, Lee S, Kang K, Park JM, Park SS, Park TH, Cho YJ, Hong KS, Lee KB, Lee J, Ryu WS, Kim DE, Nah HW, Kim DH, Cha JK, Kim JT, Cho KH, Choi JC, Oh MS, Yu KH, Lee BC, Jang MS, Lee JS, Lee J, Gorelick PB, Yoon BW, Bae HJ; CRCS-5 Investigators. Stroke. 2016 Jun;47(6):1577-83
  • 20. Warfarin Use and Risk of Stroke in Patients With Atrial Fibrillation Undergoing Hemodialysis: A Meta-Analysis. Lee M, Saver JL, Hong KS, Wu YL, Huang WH, Rao NM, Ovbiagele B. Medicine (Baltimore). 2016 Feb;95(6):e2741
  • 21. Comparative Effectiveness of Pre-stroke Aspirin on Stroke Severity and Outcome. Park JM, Kang K, Cho YJ, Hong KS, Lee KB, Hwan Park T, Lee SJ, Ko Y, Han MK, Lee J, Cha JK, Kim DH, Kim DE, Kim JT, Choi JC, Yu KH, Lee BC, Lee JS, Lee J, Gorelick PB, Bae HJ; on the behalf of CRCS-5 investigators. Ann Neurol. 2016
  • 22. Direct admission to stroke centers reduces treatment delay and improves clinical outcome after intravenous thrombolysis. Kim DH, Bae HJ, Han MK, Kim BJ, Park SS, Park TH, Lee KB, Kang K, Park JM, Ko Y, Lee SJ, Choi JC, Kim JT, Cho KH, Hong KS, Cho YJ, Kim DE, Lee J, Lee J, Oh MS, Yu KH, Lee BC, Nah HW, Cha JK. J Clin Neurosci. 2016
  • 23. Different Antiplatelet Strategies in Patients With New Ischemic Stroke While Taking Aspirin. Kim JT, Park MS, Choi KH, Cho KH, Kim BJ, Han MK, Park TH, Park SS, Lee KB, Lee BC, Yu KH, Oh MS, Cha JK, Kim DH, Nah HW, Lee J, Lee SJ, Ko YC, Kim JG, Park JM, Kang K, Cho YJ, Hong KS, Choi JC, Kim DE, Ryu WS, Shin DI, Yeo MJ, Kim WJ, Lee J, Lee JS, Saver JL, Bae HJ. Stroke. 2016 Jan;47(1):128-34
  • 24. Updated Korean Clinical Practice Guidelines on Decompressive Surgery for Malignant Middle Cerebral Artery Territory Infarction. Kim DH, Ko SB, Cha JK, Hong KS, Yu KH, Heo JH, Kwon SU, Bae HJ, Lee BC, Yoon BW, Kim JE, Kang HS, Seo DH, Park SQ, Sheen SH, Park HS, Kang SD, Kim JM, Oh CW, Park IS, Rha JH. J Stroke. 2015 Sep;17(3):369-76
  • 25. Moderate alcohol intake reduces risk of ischemic stroke in Korea. Lee SJ, Cho YJ, Kim JG, Ko Y, Hong KS, Park JM, Kang K, Park TH, Park SS, Lee KB, Cha JK, Kim DH, Lee J, Kim JT, Lee J, Lee JS, Jang MS, Han MK, Gorelick PB, Bae HJ; CRCS-5 Investigators. Neurology. 2015 Oct 30. pii: 10.1212/WNL.0000000000002165. [Epub ahead of print]
  • 26. Adherence to Guidelines for Antithrombotic Therapy in Patients with Atrial Fibrillation According to CHADS2 Score before and after Stroke: A Multicenter Observational Study from Korea. Kim WJ, Park JM, Kang K, Cho YJ, Hong KS, Lee SJ, Ko Y, Lee KB, Park TH, Lee J, Cha JK, Kim DH, Yu KH, Lee BC, Oh MS, Lee J, Lee J, Jang MS, Han MK, Bae HJ. J Clin Neurol. 2015 Nov 4. [Epub ahead of print]
  • 27. Antithrombotic Management of Patients with Nonvalvular Atrial Fibrillation and Ischemic Stroke or Transient Ischemic Attack: Executive Summary of the Korean Clinical Practice Guidelines for Stroke (Guideline). Keun-Hwa Jung, Kyung-Ho Yu, Young Dae Kim, Jong-Moo Park, Keun-Sik Hong, Joung-Ho Rha, Sun U. Kwon, Hee-Joon Bae, Ji Hoe Heo, Byung-Chul Lee, Byung-Woo Yoon. Journal of STROKE. 2015;17(2):210-215.
  • 28. Effect of Blood Pressure Lowering in Early Ischemic Stroke: Meta-Analysis. Lee M, Ovbiagele B, Hong KS, Wu YL, Lee JE, Rao NM, Feng W, Saver JL. Stroke. 2015 Jul;46(7):1883-9.
  • 29. Case characteristics, hyperacute treatment, and outcome information from the clinical research center for stroke-fifth division registry in South Korea. Kim BJ, Park JM, Kang K, Lee SJ, Ko Y, Kim JG, Cha JK, Kim DH, Nah HW, Han MK, Park TH, Park SS, Lee KB, Lee J, Hong KS, Cho YJ, Lee BC, Yu KH, Oh MS, Kim DE, Ryu WS, Cho KH, Kim JT, Choi JC, Kim WJ, Shin DI, Yeo MJ, Sohn SI, Hong JH, Lee J, Lee JS, Yoon BW, Bae HJ. J Stroke. 2015 Jan;17(1):38-53.
  • 30. Trends in the Effectiveness of Endovascular Recanalization for Acute Stroke: Is a Change Taking Place? Kim BJ, Han MK, Park TH, Park SS, Lee KB, Lee BC, Yu KH, Oh MS, Cha JK, Kim DH, Lee J, Lee SJ, Ko Y, Park JM, Kang K, Cho YJ, Hong KS, Kim JT, Choi JC, Kim DE, Lee J, Lee JS, Gorelick PB, Yoon BW, Bae HJ. J Stroke Cerebrovasc Dis. 2015;24(4):866-873.
  • 31. Modest blood pressure reduction with valsartan in acute ischemic stroke: a prospective, randomized, open-label, blinded-end-point trial. Oh MS, Yu KH, Hong KS, Kang DW, Park JM, Bae HJ, Koo J, Lee J, Lee BC; Valsartan Efficacy oN modesT blood pressUre REduction in acute ischemic stroke (VENTURE) study group. Int J Stroke. 2015 Jul;10(5):745-51.
  • 32. Cerebral Microbleeds and Early Recurrent Stroke After Transient Ischemic Attack: Results from the Korean Transient Ischemic Attack Expression Registry. Lim JS, Hong KS, Kim GM, Bang OY, Bae HJ, Kwon HM, Park JM, Lee SH, Rha JH, Koo J, Yu KH, Seo WK, Lee KB, Lee YS. JAMA Neurol. 2015;72(3):301-8.
  • 33. Grading and Interpretation of White Matter Hyperintensities Using Statistical Maps. Ryu WS, Woo SH, Schellingerhout D, Chung MK, Kim CK, Jang MU, Park KJ, Hong KS, Jeong SW, Na JY, Cho KH, Kim JT, Kim BJ, Han MK, Lee J, Cha JK, Kim DH, Lee SJ, Ko Y, Cho YJ, Lee BC, Yu KH, Oh MS, Park JM, Kang K, Lee KB, Park TH, Lee J, Choi HK, Lee K, Bae HJ, Kim DE. Stroke. 2014:45:3567-3575.
  • 34. Clinical practice guidelines for the medical and surgical management of primary intracerebral hemorrhage in Korea. Kim JE, Ko SB, Kang HS, Seo DH, Park SQ, Sheen SH, Park HS, Kang SD, Kim JM, Oh CW, Hong KS, Yu KH, Heo JH, Kwon SU, Bae HJ, Lee BC, Yoon BW, Park IS, Rha JH. J Korean Neurosurg Soc. 2014 Sep;56(3):175-87
  • 35. MRI-based Algorithm for Acute Ischemic Stroke Subtype Classification. Ko Y, Lee S, Chung JW, Han MK, Park JM, Kang K, Park TH, Park SS, Cho YJ, Hong KS, Lee KB, Lee J, Kim DE, Kim DH, Cha JK, Kim JT, Choi JC, Shin DI, Lee JS, Lee J, Yu KH, Lee BC, Bae HJ. J Stroke. 2014 Sep;16(3):161-72
  • 36. Cognitive impairment and risk of future stroke: a systematic review and meta-analysis. Lee M, Saver JL, Hong KS, Wu YL, Liu HC, Rao NM, Ovbiagele B. CMAJ. 2014 Oct 7;186(14):E536-46
  • 37. Recanalization Therapy for Internal Carotid Artery Occlusion Presenting as Acute Ischemic Stroke. Hong JH, Kang J, Kang MU, Kim BS, Han MK, Park TH, Park SS, Lee KB, Lee BC, Yu KH, Oh MS, Cha JK, Kim DH, Lee J, Lee SJ, Ko Y, Park JM, Kang K, Cho YJ, Hong KS, Cho KH, Kim JT, Lee J, Lee JS, Bae HJ. 2014 J Stroke Cerebrovasc Dis. 2014 Sep;23(8):2183
  • 38. Physicians’ attitude towards the stroke guideline: a survey of Korean neurologists. Hyung-Min Kwon, Mi Sun Oh, Hye-Yeon Choi, A-Hyun Cho, Keun-Sik Hong, Kyung-Ho Yu, Hee-Joon Bae, Juneyoung Lee, Byung-Chul Lee. J Stroke. 2014;16(2):81-85.
  • 39. Off-hour effect on 3-month functional outcome after acute ischemic stroke: a prospective multicenter registry. Kim C, Jang MU, Oh MS, Park JH, Jung S, Lee JH, Yu KH, Han MK, Kim BJ, Park TH, Park SS, Lee KB, Cha JK, Kim DH, Lee J, Kim SH, Lee SJ, Ko Y, Park JM, Kang K, Cho YJ, Hong KS, Cho KH, Kim JT, Kim DE, Choi JC, Jang MS, Bae HJ, Lee BC; CRCS-5 investigators. PLoS One. 2014 Aug 28;9(8):e105799
  • 40. Symptomatic steno-occlusion in patients with acute cerebral infarction: prence, distribution, and functional outcome. Kang J, Park TH, Lee KB, Park JM, Ko Y, Lee SJ, Hong KS, Cho YJ, Lee JS, Lee J, Lee BC, Yu KH, Kim DH, Cha JK, Lee J, Jang MS, Han MK, Bae HJ. J Stroke. 2014 Jan;16(1):36-43.
  • 41. Predictors of Symptomatic and Asymptomatic Intracranial Atherosclerosis: What is Different and Why? Joon Kim B, Hong KS, Cho YJ, Lee JH, Koo JS, Park JM, Kang DW, S Kim J, Lee SH, U Kwon S, Behalf Of Toss-Investigators O. J Atheroscler Thromb. 2014;21(6):605-617.
  • 42. Current Status of Recanalization Therapy in Acute Ischemic Stroke with Symptomatic Intracranial Arterial Occlusion in Korea. Jang MU, Hong JH, Kang J, Kim BJ, Han MK, Lee BC, Yu KH, Oh MS, Hong KS, Cho YJ, Park JM, Kang K, Cha JK, Kim DH, Park TH, Lee KB, Lee SJ, Ko Y, Lee J, Cho KH, Kim JT, Lee J, Lee JS, Bae HJ. J Stroke Cerebrovasc Dis. 2014 May-Jun;23(5):e339-46
  • 43. Delayed-phase CT angiography is superior to arterial-phase CT angiography at localizing occlusion sites in acute stroke patients eligible for intra-arterial reperfusion therapy. Chung HJ, Lee BH, Hwang YJ, Kim SY, Lee JY, Kim YS, Hong KS, Cho YJ, Park JH. J Clin Neurosci 2014;21:596
  • 44. Current status of acute stroke management in Korea: a report on a multicenter, comprehensive acute stroke registry. Kim BJ, Han MK, Park TH, Park SS, Lee KB, Lee BC, Yu KH, Cha JK, Kim DH, Lee J, Lee SJ, Ko Y, Park JM, Kang K, Cho YJ, Hong KS, Cho KH, Kim JT, Kim DE, Lee J, Lee JS, Jang MS, Broderick JP, Yoon BW, Bae HJ; CRCS-5 investigators. Int J Stroke. 2014;9(4):514-518
  • 45. Gender differences in the age-stratified prence of risk factors in Korean ischemic stroke patients: a nationwide stroke registry-based cross-sectional study. Park TH, Ko Y, Lee SJ, Lee KB, Lee J, Han MK, Park JM, Kim DE, Cho YJ, Hong KS, Kim JT, Cho KH, Kim DH, Cha JK, Yu KH, Lee BC, Yoon BW, Lee JS, Lee J, Gorelick PB, Bae HJ. Int J Stroke. 2014;9(6):759-765.
  • 46. The iScore Predicts Clinical Response to Tissue Plasminogen Activator in Korean Stroke Patients. Park TH, Park SS, Ko Y, Lee SJ, Lee KB, Lee J, Kang K, Park JM, Choi JC, Kim DE, Cho YJ, Hong KS, Kim JT, Kim DH, Cha JK, Han MK, Lee JS, Lee J, Yu KH, Lee BC, Yoon BW, Bae HJ, Saposnik G. J Stroke Cerebrovasc Dis. 2014 Feb;23(2):367-73
  • 47. Cefepime- Induced Non-Convulsive Status Epilepticus (NCSE). Kim A, Kim JE, Paek YM, Hong KS, Cho YJ, Cho JY, Park HK, Koo HK, Song P. J Epilepsy Res. 2013 Jun 30;3(1):39-41.
  • 48. Risk-Benefit Profile of Long-Term Dual- Versus Single-Antiplatelet Therapy Among Patients With Ischemic Stroke: A Systematic Review and Meta-analysis. Lee M, Saver JL, Hong KS, Rao NM, Wu YL, Ovbiagele B. Ann Intern Med. 2013 Oct 1;159(7):463-70.
  • 49. Efficacy and safety of an early Solitaire stent retri technique for acute ischemic stroke. Lee BH, Hwang YJ, Hong KS, Cho YJ. Jpn J Radiol. 2013 Sep;31(9):608-13.
  • 50. Deep subcortical infarct burden in relation to apolipoprotein B/AI ratio in patients with intracranial atherosclerotic stenosis. Park JH, Hong KS, Lee J, Kim YJ, Song P. Eur J Neurol. 2013 Apr;20(4):671-80
  • 51. Risk-benefit Profile of Warfarin vs. Aspirin in Patients with Heart Failure and Sinus Rhythm: A Meta-Analysis. Lee M, Saver JL, Hong KS, Wu HC, Ovbiagele B. Circ Heart Fail. 2013:6:287
  • 52. Weekend admission in patients with acute ischemic stroke is not associated with poor functional outcome than weekday admission. Kim SC, Hong KS, Hwang SI, Kim JE, Kim AR, Cho JY, Park HK, Park JH, Koo JS, Park JM, Bae HJ, Han MK, Kang DW, Oh MS, Yu KH, Lee BC, Lee JS, Cho YJ. J Clin Neurol. 2012 Dec;8(4):265-70.
  • 53. Pulmonary thromboembolism in a patient with myotonic dystrophy type 1. Cho JY, Seo SY, Cho YJ, Hong KS, Park HK, Lee JH, Lee SS. Ann Indian Acad Neurol. 2012;15:317-9.
  • 54. Reperfusion Therapy in Unclear-Onset Stroke Based on MRI Evaluation (RESTORE): A Prospective Multi-center Study. Dong-Wha Kang, Sung-Il Sohn, Keun-Sik Hong, Kyung-Ho Yu, Yang-Ha Hwang, Moon-Ku Han, Jun Lee, Jong-Moo Park, A-Hyun Cho, Hye-Jin Kim, Dong-Eog Kim, Yong-Jin Cho, Jaseong Koo, Sung-Cheol Yun, Sun U. Kwon, Hee-Joon Bae, and Jong S Kim. Stroke. 2012 Dec;43(12):3278-83
  • 55. Risk of intracranial hemorrhage with protease-activated receptor-1 antagonists. Lee M, Saver JL, Hong KS, Wu HC, Ovbiagele B. Stroke. 2012 Dec;43(12):3189-95.
  • 56. Predictors of Recurrent Stroke in Patients With Symptomatic Intracranial Arterial Stenosis. Jung JM, Kang DW, Yu KH, Koo JS, Lee JH, Park JM, Hong KS, Cho YJ, Kim JS, Kwon SU; on behalf of the TOSS-2 Investigators. Stroke. 2012 Oct;43(10):2785-7.
  • 57. Efficacy of folic acid supplementation in cardiovascular disease prevention: An updated meta-analysis of randomized controlled trials. Yang HT, Lee M, Hong KS, Ovbiagele B, Saver JL. Eur J Intern Med. 2012 Dec;23(8):745-54
  • 58. Effect of pre-diabetes on future risk of stroke: meta-analysis. Lee M, Saver JL, Hong KS, Song S, Chang KH, Ovbiagele B. BMJ. 2012 Jun 7;344:e3564.
  • 59. Secular Trends in Ischemic Stroke Characteristics in a Rapidly Developed Country: Results From the Korean Stroke Registry Study (Secular Trends in Korean Stroke). Jung KH, Lee SH, Kim BJ, Yu KH, Hong KS, Lee BC, Roh JK; Korean Stroke Registry Study Group. Circ Cardiovasc Qual Outcomes. 2012 May;5(3):327-34.
  • 60. Association Between Changes in Lipid Profiles and Progression of Symptomatic Intracranial Atherosclerotic Stenosis: A Prospective Multicenter Study. Kim DE, Kim JY, Jeong SW, Cho YJ, Park JM, Lee JH, Kang DW, Yu KH, Bae HJ, Hong KS, Koo JS, Lee SH, Lee BC, Han MK, Rha JH, Lee YS, Kim GM, Chae SL, Kim JS, Kwon SU. Stroke. 2012 Jul;43(7):1824-30.
  • 61. Stroke units and stroke care services in Korea. Choi HY, Cha MJ, Nam HS, Kim YD, Hong KS, Heo JH; the Korean Stroke Unit Study Collaborators. Int J Stroke. 2012 Jun;7(4):336-40.
  • 62. Does achieving an intensive versus usual blood pressure level prevent stroke? Lee M, Saver JL, Hong KS, Hao Q, Ovbiagele B. Ann Neurol 2012 Jan;71(1):133-40.
  • 63. Renin-Angiotensin System Modulators Modestly Reduce Vascular Risk in Persons With Prior Stroke. Lee M, Saver JL, Hong KS, Hao Q, Chow J, Ovbiagele B. Stroke 2012 Jan;43(1):113-9.
  • 64. High Levels of Apolipoprotein B/AI Ratio Are Associated With Intracranial Atherosclerotic Stenosis. Park JH, Hong KS, Lee EJ, Lee J, Kim DE. Stroke 2011 Nov;42(11):3040-6.
  • 65. Efficacy and Safety of Combination Antiplatelet Therapies in Patients with Symptomatic Intracranial Atherosclerotic Stenosis. Sun U. Kwon, Keun-Sik Hong, Dong-Wha Kang, Jong-Moo Park, Ju-Hun Lee, Yong-Jin Cho, Kyung-Ho Yu, Ja-Seong Koo, KS Lawrence Wong, Seung-Hoon Lee, Kyung Bok Lee, Dong-Eog Kim, Sang-Wook Jeong, Hee-Joon Bae, Byung-Chul Lee, Moon-Ku Han, Joung-Ho Rha, Hahn Young Kim, Vincent C Mok, Yong-Seok Lee, Gyeong-Moon Kim, Nijasri Charnnarong Suwanwela, Sung-Cheol Yun, Hyun-Wook Nah, Jong S. Kim. Stroke 2011 Oct;42(10):2883-90.
  • 66. Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): A Randomized Double-Blind Non-Inferiority Trial. Lee YS, Bae HJ, Kang DW, Lee SH, Yu K, Park JM, Cho YJ, Hong KS, Kim DE, Kwon SU, Lee KB, Rha JH, Koo J, Han MG, Lee SJ, Lee JH, Jung SW, Lee BC, Kim JS. Cerebrovasc Dis. 2011;32(1):65-71.
  • 67. Comparison of 90-day case-fatality after ischemic stroke between two different stroke outcome registries using Propensity Score Matching Analysis. Kyung-Ho Yu, Keun-Sik Hong, Byung-Chul Lee, Mi-Sun Oh, Yong-Jin Cho, Ja-Seong Koo, Jong-Moo Park, Hee-Joon Bae, Moon-Ku Han, Young-Su Ju, Dong-Wha Kang, Peter Appelros, Bo Norrving, Andreas Terent. Acta Neurol Scand 2011;123(5):325-31.
  • 68. Unilateral Prosopometamorphopsia as a Dominant Specific Disconnection Sign. Joong-Yang Cho, So Young Moon, Keun-Sik Hong, Yong-Jin Cho, Sang-Chul Kim, Sun-Il Hwang, So-Young Seo, Ji-Eun Kim, Hee Kyung Park. Neurology 2011;76:e110.
  • 69. Taste function in patients with Parkinson disease. Han-Joon Kim, Beom S. Jeon, Jee-Young Lee, Yong-Jin Cho, Keun-Sik Hong, Joong-Yang Cho. Journal of Neurology 2011;2581076-1079.
  • 70. A computerized physician order entry-based code stroke system for thrombolysis in acute stroke. Heo JH, Kim YD, Nam HS, Hong KS, Ahn SH, Cho HJ, Choi HY, Han SW, Cha MJ, Hong JM, Kim GM, Kim GS, Kim HJ, Kim SH, Kim YJ, Kwon SU, Lee BC, Lee JH, Lee KH, Oh MS. Stroke 2010;41:1978.
  • 71. Efficacy of homocysteine-lowering therapy with folic Acid in stroke prevention: a meta-analysis. Lee M, Hong KS, Saver JL. Stroke. 2010 Jun;41(6):1205-12.
  • 72. Efficacy of intra-arterial fibrinolysis for acute ischemic stroke: meta-analysis of randomized controlled trials. Lee M, Hong KS, Saver JL. Stroke. 2010 May;41(5):932-7.
  • 73. Taste function in patients with Parkinson disease. Kim HJ, Jeon BS, Lee JY, Cho YJ, Hong KS, Cho JY. J Neurol 2011 Jun;258(6):1076-9.
  • 74. Taste sense in patients with hemifacial spasm. Kim HJ, Lee DH, Cho JY, Cho YJ, Hong KS. J Clin Neurosci. 2010 Jul;17(7):950-1.
  • 75. Levosulpiride-induced resting orolingual tremor. Kim HJ, Cho JY, Cho YJ, Hong KS. Mov Disord. 2009 Aug 15;24(11):1700-1.
  • 76. Acute subdural hematoma following spinal cerebrospinal fluid drainage in a patient with freezing of gait. Kim HJ, Cho YJ, Cho JY, Lee DH, Hong KS. J Clin Neurol. 2009 Jun;5(2):95-6.
  • 77. Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment. Kim HJ, Park SY, Cho YJ, Hong KS, Cho JY, Seo SY, Lee DH, Jeon BS. J Neurol Sci. 2009 Dec 15;287(1-2):200-4.
  • 78. Severe jabbing headache associated with airplane travel. Kim HJ, Cho YJ, Cho JY, Hong KS. Can J Neurol Sci. 2008 May;35(2):267-8.
  • 79. Choreodystonia in a patient with hypertrophic olivary degeneration after pontine tegmental hemorrhage. Kim HJ, Cho YJ, Cho JY, Hong KS, Jeon BS. Mov Disord. 2008 30;23(6):920-2.
  • 80. Phenylpropanolamine contained in cold remedies and risk of hemorrhagic stroke. B.W. Yoon, H.J. Bae, K.S. Hong, S.M. Lee, B.J. Park, K.H. Yu, M.K. Han, Y.S. Lee, D.K. Chung, J.M. Park, S.W. Jeong, B.C. Lee, K.H. Cho, MD, J.S. Kim, S.H. Lee, K.M. Yoo; for the Acute Brain Bleeding Analysis (ABBA)Study Investigators. Neurology 2007;68:146?149.
  • 81. Cilostazol Prevents the Progression of the Symptomatic Intracranial Arterial Stenosis: The Multicenter Double-Blind Placebo-Controlled Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis. Sun U. Kwon, MD, PhD; Yong-Jin Cho, MD, PhD; Ja-Seong Koo, MD; Hee-Joon Bae, MD, PhD; Yong-Seok Lee, MD; Keun-Sik Hong, MD, PhD; Jun Hong Lee, MD; Jong S. Kim, MD, PhD. Stroke 2005;36:782-786.
  • 82. Prognostic factors for the surgery for mesial temporal lobe epilepsy: Longitudinal analysis. Sang-Wuk Jeong, Sang Kun Lee, Keun-Sik Hong, Kwang-Ki Kim, Chun-Kee Chung, Ho Kim. Epilepsia 2005;46(8):1273-1279.
  • 83. Surgical outcome and prognostic factors of cryptogenic neocortical epilepsy. Sang Kun Lee, Seo Young Lee, Keun-Sik Hong, Kwang-Ki Kim, Dong-Soo Lee, Chun-Kee Chung. Ann Neurol 2005;58:525-532.
  • 84. Intracranial Cerebral Artery Disease as a Risk Factor for Central Nervous System Complications of Coronary Artery Bypass Graft Surgery. Byung-Woo Yoon, Hee-Joon Bae, Dong-Wha Kang, Seung-Hoon Lee, Keun-Sik Hong, Ki-Bong Kim, Byung Joo Park, Jae-Kyu Roh. Stroke 2001;32:94-99.
  • 85. Neuroimaging findings of cortical dyslamination with cytomegaly. Sang Kun Lee, Gheeyoung Choe, Keun-Sik Hong, Joo-Yong Kim, Chun-Kee Chung, Dong-Soo Lee, Kee-Hyun Chang. Epilepsia 2001;42:850-856.
  • 86. Incidence and clinical profile of extra-medial-temporal epilepsy with hippocampal atrophy. Hyunwoo Nam, Sang Kun Lee, Chun-Kee Chung, Keun-Sik Hong, Kee-Hyun Chang, Dong-Soo Lee. J Korean Med Sci 2001;16:95-102.
  • 87. The Clinical Usefulness of Ictal Surface EEG in Neocortical Epilepsy. Sang Kun Lee, Joo-Yong Kim, Keun-Sik Hong, Hyun-Woo Nam, Sung-Ho Park, and Chun-Ki Chung. Epilepsia 2000;41(11):1450-1455.
  • 88. The lateralizing and surgical prognostic value of a single 2-hour EEG in mesial TLE. Sang Kun Lee, Kwang-Ki Kim, Keun-Sik Hong, Joo-Yong Kim, Chun-kee Chung. Seizure 2000;9:336-339.
  • 89. Outcomes of medical treatment of neurocysticercosis: a study of 65 cases in Cheju island, Korea. Seung-Ki Kim, Kyu-Chang Wang, Sun-Ha Paek, Keun-Sik Hong, Byung-Kyu Cho. Surg Neurol 1999;52:563-569.

  • As a First, corresponding, or co-author in domestic journals (in Korean):
  • 1. Update of the Korean Clinical Practice Guidelines for Endovascular Recanalization Therapy in Patients with Acute Ischemic Stroke. Keun-Sik Hong, Sang-Bae Ko, Kyung-Ho Yu, Cheolkyu Jung, Sukh Que Park, Byung Moon Kim, Chul-Hoon Chang, Hee-Joon Bae, Ji Hoe Heo, Chang Wan Oh, Byung-Chul Lee, Bum-Tae Kim, Bum-soo Kim, Chin-Sang Chung, Byung-Woo Yoon, Joung-Ho Rha. J Korean Neurol Assoc 2016;34:297-311.
  • 2. Endovascular Trials in Acute Ischemic Stroke Since 1998: What We Have Achieved. Keun-Sik Hong. J Korean Neurol Assoc 2015; Suppl:78-84.
  • 3. Mechanical Thrombectomy Using a Solitaire Stent in Acute Ischemic Stroke: The Relationship between the Visible Antegrade Flow on First Device Deployment and Final Success in Revascularization. Lee SH, Lee BH, Hwang YJ, Kim SY, Lee JY, Hong KS, Cho YJ. J Korean Soc Radiol. 2015 May;72(5):313-318.
  • 4. Review of Evidences and Updates of the Korean Clinical Practice Guidelines for Stroke in 2013. Keun-Sik Hong, Kyung-Ho Yu, Joung-Ho Rha, Hahn Young Kim, Jaseong Koo, Jong-Moo Park, Dae-Hee Seo, In Sung Park, Kyung-Hee Cho, Keun-Hwa Jung, Tai Hwan Park, Byung-Chul Lee, Byung-Woo Yoon. J Korean Neurol Assoc 2013;31(3):143-157.
  • 5. Focused Update of Korean Clinical Practice Guidelines for the Thrombolysis in Acute Stroke Management. Kyung-Hee Cho, Sang-Bae Ko, Dae-Hyun Kim, Hee-Kwon Park, A-Hyun Cho, Keun-Sik Hong, Kyung-Ho Yu, Ji Hoe Heo, Sun-Uck Kwon, Hee-Joon Bae, Chang Wan Oh, O-Ki Kwon, Byung-Chul Lee, Byung-Woo Yoon, Joung-Ho Rha. Korean J Stroke 2012;14(3):95-105.
  • 6. Focused Update on Primary Stroke Prevention in Patients with Atrial Fibrillation in Korean Clinical Practice Guidelines for Stroke. Jong-Moo Park, Keun-Sik Hong, Sang Won Han, Hahn Young Kim, Yong-Jin Cho, Kyusik Kang, Kyung-Ho Yu, Joung-Ho Rha, Ji Hoe Heo, Sun-Uck Kwon, Chang Wan Oh, Hee-Joon Bae, Byung-Chul Lee, Byung-Woo Yoon, Jaseong Koo. Korean J Stroke 2012;14(3):106-115.
  • 7. Korean Stroke Clinical Practice Guidelines Updates. Keun-Sik Hong. Korean Society of Geriatric Neurology. 2013;173-185.
  • 8. 2011 Update of Scientific Statement for the Primary Prevention of Stroke: Dyslipidemia and Inflammation. Han SW, Kim HY, Park JM, Koo J, Cho YJ, Kang K, Yu KH, Rha JH, Heo JH, Kwon SU, Oh CW, Bae HJ, Lee BC, Yoon BW, Chung CS, Hong KS. J Korean Neurol Assoc. 2012 Aug;30(3):159-169.
  • 9. Management of Asymptomatic Carotid Stenosis for Primary Stroke Prevention: 2012 Focused Update of Korean Clinical Practice Guidelines for Stroke. Kim HY, Kim SR, Jeon P, Kang HS, Kang K, Koo J, Park JM, Cho YJ, Han SW, Yu KH, Rha JH, Heo JH, Kwon SU, Oh CW, Bae HJ, Lee BC, Yoon BW, Hong KS. J Korean Neurol Assoc 2012;30(2):77-87.
  • 10. Antiplatelet Therapy for Secondary Stroke Prevention: 2012 Focused Update of Korean Clinical Practice Guidelines for Stroke. Park TH, Kim MK, Oh HG, Oh MS, Yu KH, Hong KS, Bae HJ, Kwon SU, Rha JH, Heo JH, Oh CW, Lee BC, Yoon BW. Korean J Stroke. 2012 Apr;14(1):1-5.
  • 11. Guidelines for the Management of Unruptured Intracranial Aneurysm. Seo DH, Kang HS, Kim DW, Park SQ, Song Y, Sheen SH, You SH, Kwon SU, Rha JH, Bae HJ, Oh CW, Yu KH, Yoon BW, Lee BC, Heo JH, Hong KS, Hong SC, Park IS. Korean J Cerebrovasc Surg. 2011 Dec;13(4):279-290.
  • 12. Measuring and Analysis of Outcome in Stroke Trials. Keun-Sik Hong. Korean J Stroke. 2011;13(1):1-10.
  • 13. Focused Update on Aspirin for Primary Stroke Prevention in Korean Clinical Practice Guidelines for Stroke. Jaseong Koo, Sang Won Han, Hahn Young Kim, Jong-Moo Park, Yong-Jin Cho, Kyusik Kang, Kyung-Ho Yu, Joung-Ho Rha, Ji Hoe Heo, Sun-Uck Kwon, Chang Wan Oh, Hee-Joon Bae, Byung-Chul Lee, Byung-Woo Yoon, Keun-Sik Hong. J Korean Neurol Assoc 2011;29(4):277-284.
  • 14. The Factors Associated with the Decision of r-tPA Use in Acute Ischemic Stroke Patients Aged 80 Years or Older. Jeong MG, Kim Y, Kim YJ, Oh MS, Yu KH, Lee BC, Lee JH, Kwon JH, Kwon SU, Heo SH, Choi JC, Kwon HM, Park JM, Kim EG, Rha JH, Park HK, Bae HJ, Han MK, Hong KS, Cho YJ, Park MS, Cho KH, Kim HY, Lee J, Kim DE, Lee SJ, Lee KB, Park TH, Cha MJ, Heo JH, Nam HS, Cha JK, Kim CH, Yoon BW. Korean J Stroke. 2011;13(2):79-84.
  • 15. Focused Update of 2009 Korean Clinical Practice Guidelines for the Surgical or Interventional treatment of Extracranial Carotid Artery Stenosis in Secondary Prevention of Stroke. Jung KH, Yu KH, Kwon OK, Park HS, Hong KS, Heo JH, Kwon SU, Oh CW, Bae HJ, Lee BC, Kim SR, Park IS, Yoon BW. Korean J Stroke. 2011 Dec;13(3):99-106.
  • 16. Progression of Acute Ischemic Infarction after a Hemostatic Therapy for Thrombolysis-Related Intracerebral Hemorrhage. Seon-Il Hwang, Sang-Chul Kim, Ji Eun Kim, Joong-Yang Cho, Hee Kyung Park, Ji-Hyeon Park, Yong-Jin Cho, Keun-Sik Hong. Korean J Stroke. 2011;13:41-44.
  • 17. Focused Update of 2009 Korean Clinical Practice Guidelines for the Antiplatelet Therapy in Secondary Prevention of Stroke. Hyung-Min Kwon, Kyung-Ho Yu, Keun-Sik Hong, Joung-Ho Rha, Ji Hoe Heo, Sun Uck Kwon, Chang Wan Oh, Hee-Joon Bae, Byul-Chul Lee, Byung-Woo Yoon, for the Clinical Practice Guideline writing group in Clinical Research Center for Stroke. J Korean Neurol Assoc. 2010;28(2):81-84.
  • 18. Stroke Update 2010: Clinical Stroke. Keun-Sik Hong. Korean Neurol Assoc. 2010;28(suppl 2):2-9.
  • 19. Cerebral Air Embolism after Removing Central Venous Catheter. So-Young Seo, Dong-Ha Lee, Sun-Il Hwang, Sang-Chul Kim, Keun-Sik Hong, Joong-Yang Cho, Ji-Young Lee, Hee Kyung Park, Yong-Jin Cho. Korean J Stroke. 2010;12:2:68-72.
  • 20. Outcome and Prognostic Factor of Isolated Anterior Cerebral Artery Territory Infarction. Eun-Jin Oh, Keun-Sik Hong, Joong-Yang Cho, Han-Joon Kim, Dong-Wha Kang, Ja-Seong Koo, Jong-Moo Park, Hee-Joon Bae, Moon-Ku Han, Kyung-Ho Yu, Byung-Chul Lee, Jong-Kwan Park, Yong-Jin Cho. Korean J Stroke. 2009;11:19-24.
  • 21. A Case of Compressive Myelopathy due to Ossification of the Cervical Ligamentum Flavum. Dong-Ha Lee, Yong-Jin Cho, Han-Joon Kim, Keun-Sik Hong, Joong-Yang Cho. Korean J Clin Neurophysiol 2008;10:109-111.
  • 22. Acute Stroke Therapy: 2007 Update. Keun-Sik Hong. Korean Journal of Stroke. 2008;10:10-19.
  • 23. Two Cases of Sudden Hearing Loss With Vertigo as an Isolated Symptom of Anterior Inferior Cerebellar Artery Infarction. Park SY, Shin JW, Cho YJ, Hong KS. J Korean Bal Soc. 2008 Jun;7(1):85-88.
  • 24. Challenging therapy for acute stroke. Keun-Sik Hong. Korean Journal of Stroke 2007;9:18-23.
  • 25. Primary prevention of Stroke. Jong-Moo Park, Ja-Seong Koo, Yong-Jin Cho, Hahn Young Kim, Sang Won Han, Kyusik Kang, Keun-Sik Hong. Korean Neurol Assoc 2007;25(suppl):344-358)
  • 26. Clinical Practice Guidelines for Stroke: Global Status. Keun-Sik Hong. Koran Journal of Stroke 2007;9:99-107.
  • 27. Development of quality indicators for stroke care. Keun-Sik Hong, Jai-Yong Kim. Korean Journal of Stroke 2006;8(1):17-25.
  • 28. A case of thyrotoxic periodic paralysis with dysfunction of sensory nerve action potential amplitude during attack. So-Young Park, Joong-Yang Cho, Jong-Kwan Park, Dong-Ha Lee, Yong-Jin Cho, Han-Joon Kim, Keun-Sik Hong. Journal of Korean Society for Clinical Neurophysiology 2007;9(1):39-41.
  • 29. Outcome Measure and Efficacy Analysis in Stroke Clinical Trials. Keun-Sik Hong. J Korean Neurol Assoc 2006;24(5):411-420.
  • 30. A Case of Ischemic Stroke Associated with Phendimetrazine as an Appetite Suppressant. Jong-Kwan Park, Keun-Sik Hong, Yong-Jin Cho, Sang-Wuk Jeong, Eun-Jin Oh, So-Young Park, Dong-Ha Lee, Joong-Yang Cho. J Korean Neurol Assoc 2006;24(5):465-467.
  • 31. Analysis of 10,811 Cases with Acute Ischemic Stroke from Korean Stroke Registry: Hospital-Based Multicenter Prospective Registration Study. Kyung-Ho Yu, Hee-Jun Bae, Sun Uck Kwon, Dong-Wha Kang, M.D.b, Keun-Sik Hong, Yong-Seok Lee, Joung-Ho Rha, Ja-Seong Koo, Jong Sung Kim, Jin-Hyuck Kim, Ju-Hun Lee, Soo-Jin Cho, Sung-Hee Hwang, San Jung, Moon-Ku Han, Ki-Hyun Cho, Byeong-Chae Kim, Dong-Jin Shin, Dae-Il Chang, Jae Hyeon Park, Eung-Gyu Kim, Dae Soo Jung, Moo Young Ahn, Dae-Hie Lee, KunWoo Park, Yong-Jae Kim, Kyung Yul Lee, Ji Hoe Heo, Seung Hyun Kim, Kwang Ho Lee, Chin-Sang Chung, Jae-Kwan Cha, Jun-Hong Lee, Keun-Yong Uhm, Byung-Chul Lee, Jae-Kyu Roh. Korean Neurol Assoc 2006;24(6): 535~543.
  • 32. Hippocampal Neurogenesis and Its Phenotypic Differentiation after Kainic Acid-induced Seizures in Mice. Eun Sil Choi, Sang-Wuk Jeong, Hyun Oh Jang, Keun-Sik Hong, Dong Wook Kim. J Korean Neurol Assoc 2005;23(4):503-509.
  • 33. Painless Aortic Dissection Simulating Guillain-Barre Syndrome. Eun-Jin Oh, Sang-Wuk Jeong, Jong-Kwan Park, Keun-Sik Hong. Journal of Korean Society for Clinical Neurophysiology 2005;7(1):49-51.
  • 34. The Safety and Efficacy of Intravenous t-PA Therapy for Acute Ischemic Stroke in a Community-Based University Hospital. Eun-Jin Oh, Sang-Wuk Jeong, Jong-Kwan Park, Keun-Sik Hong. Korean Journal of Stroke 2005;7(1):70 - 77.
  • 35. Abnormalities in Electroencephalography. Keun-Sik Hong. Journal of Korean Society for Clinical Neurophysiology 2005;7(1):173-181.
  • 36. Cardiovascular Safety of Triptan. Keun-Sik Hong. The Korean Journal of Headache 2004;5:115-124.
  • 37. Electroencephalography. Keun-Sik Hong. Journal of Korean Society for Clinical Neurophysiology 2004; 6(1):118-126.
  • 38. Reversible Vasculopathy in Tuberculous Meningitis: Transcranial Doppler and Magnetic Resonance Angiography Study. Won-Kyoo Kim, Keun-Sik Hong, Yong-Jin Cho, Eun-Jin Oh, Sang-Wuk Jeong. Korean Neurol Assoc 2004;22(2):134-136.
  • 39. Clinical Electroencephalography. Keun-Sik Hong. Journal of Korean Society for Clinical Neurophysiology 2004;6(2):80-85.
  • 40. A Case of Cauda Equina Schwannoma Presenting as Normal Pressure Hydrocephalus. Yong-Jin Cho, Won-Kyoo Kim, Choong Jin Whang, Keun-Sik Hong. J Korean Neurol Assoc 2003;21(2):213-216.
  • 41. Predicting Factors in the Development of Pneumonia after Acute Stroke. Hyung-Min Kwon, Sang-Wuk Jeong, Keun-Sik Hong, Mun-Gu Han, Kon Chu, Byung-Woo Yoon. J Korean Neurol Assoc 2003;21(5):455-460.
  • 42. Common neurological problems in elderly. Keun-Sik Hong. J Korean Geriatr Soc 2003;7(suppl 3):114-121.
  • 43. Migraine and Comorbidities. Keun-Sik Hong. The Korean Journal of Headache 2002; 3(1):39-49.
  • 44. Migraine and epilepsy. Keun-Sik Hong. The Korean Journal of Headache 2001; 2(1):35-42.
  • 45. A study on the plasma level of carbamazepine and its epoxide in adult Korean patients with epilepsy. Hyunwoo Nam, Sung-Shin Ahn, Sang-Kun Lee, Kyung-Seok Park, Keun-Sik Hong, Sang-Goo Shin, In-Jin Jang, Ju-Han Kim, Hyeon-Mi Park, Dong-Seok Yim. Kor J Clin Pharmcol Ther 2000;8(2): 178-184.
  • 46. A Case of Neurological Complications after Liver Transplantation. Keun-Sik Hong, Sang-Kun Lee, Sang-Yoon Kim, Kuhn Uk Lee, Kyung-Seok Seo. J Korean Neurol Assoc 2000;18(1):116-118.
  • 47. Chronological Changes in the Rotational Behavior in Response to Apomorphine Administration in 6-Hydroxydopamine Parkinsonian Rat. Keun-Sik Hong, Byung Gon Kim, Beom S. Jeon, Byung-Woo Yoon, Kwang-Woo Lee, Jae-Kyu Roh, Sang-Bok Lee, Ho-Jin Myung. J Korean Neurol Assoc 1999;17(1):117-121.
  • 48. Central nervous system complications of coronary artery bypass graft surgery. Hee-Joon Bae, Byung-Woo Yoon, Dong-Wha Kang, Sung-Hun Kim, Keun-Sik Hong, Ki-Bong Kim, Jae-Kyu Roh. J Korean Neurol Assoc 1998;16(6):769-774.
  • 49. Differential effect of NMDA antagonists on D1 & D2 mediated rotation responses in 6- hydroxydopamine (6-OHDA) lesioned rat. Keun-Sik Hong, Kyung Moon Kim, Byung Woo Yoon, Beom S.Jeon. J Korean Neurol Assoc 1997;15(1):99-108.
  • 50. CNS Complications of Open heart Surgery. Jae Kyu Roh, Keun-Sik Hong, Byung-Woo Yoon. J Korean Neurol Assoc 1995;13(2):326-333.
  • 51. Evaluation of Cerebrovascular Reactivity in Normal and Atherosclerotic Subjects ; using Transcranial Doppler. Keun-Sik Hong, Jae Kyu Roh. J Korean Neurol Assoc 1994;12(2):237-244.

  • Citations
  • Current Citations: http://scholar.google.com/citations?user=H8qr5okAAAAJ&hl=en
  • Or https://www.researchgate.net/profile/Keun_Sik_Hong

  • Invited Lectures
  • Invited lectures at academic societies since 2006
  • 1. AUG 2017, Reperfusion Treatment Status in Korea: Data from Large Multicenter Prospective Stroke Registry at the 2017 Australasian Stroke Academy, Melbourne, AUS
  • 2. FEB 2017, Status Reperfusion therapy in acute ischemic stroke in Korea at the 2017 International Stroke Conference, LA, USA
  • 3. Oct 2016, Lipid management for primary and secondary stroke prevention and acute cerebral ischemia. At the 13th International Symposium on Thrombolysis Thrombectomy and Acute Stroke Therapy (TTST 2016), Kobe, Japan
  • 4. Oct 2016, What Should We Know about Stroke? At the 2016 9th Asia Pacific Heart Rhythm Society Scientific Session
  • 5. Sep 2016, RCT Design for Clopidogrel Versus ASA in Acute Ischemic Stroke. At the International Conference STROKE UPDATE/International Conference on Intracranial Atherosclerosis 2016.
  • 6. Jul 2016, Advances and debates in the management of ICAS: 13th SMC Stroke Center Symposium
  • 7. May 2016, Blood pressure management for the prevention of stroke and major vascular events. at the Annual Meeting of the Korean Stroke Society.
  • 8. Oct 2015, Endovascular trials in acute ischemic stroke since 1998: What we have achieved at the 34th Annual Meeting of the Korean Neurological Association
  • 9. Oct 2015, Statin for the management of dyslipidemia in acute ischemic stroke at the 7th Japanese-Korean Joint Stroke Conference
  • 10. Oct 2015, Stroke CPG: Korean Experience at the 2105 Asia Pacific Stroke Conference
  • 11. Oct 2015, Statin and Stroke at the 59th Annual Scientific Meeting of the Korean Society of Cardiology
  • 12. Sep 2015, Hyperacute stroke treatment in Korea at the 2015 SNUH International Stroke Symposium
  • 13. Aug 2015, Differences between Cerebrovascular and Coronary Heart Diseases at the 2015 Korean Vascular Research Working Group Educational Course
  • 14. Apr 2015, Stroke epidemiology and acute stroke management in Korea at the East Asia Neurology Forum
  • 15. Feb 2015, Update of Secondary Stroke Prevention 2015 at the Update Educational Course of the Korean Stroke Society
  • 16. Nov 2014, Current status of acute ischemic stroke management in Korea at the International Conference Stroke Update 2014
  • 17. Nov 2014, Acute Stroke Cases at the Annual Meeting of the Korean Neurological Association
  • 18. Sep 2014, Cons: Aortic plaque screening should not be a routine uation at the 2014 SNUH International Stroke Symposium
  • 19. Jul 2014, Korean Stroke Guidelines: Current Status and Future at the 34th Scientific Congress of the Korean Medical Association
  • 20. May 2014, Polyvascular disease in stroke patients at the Annual Meeting of the Korean Stroke Society.
  • 21. May 2014, Hypertension management for primary prevention of stroke at the Annual Meeting of the Korean Society of Hypertension.
  • 22. Feb 2014, Stroke outcome and prognosis at the Stroke Update Symposium of the Korean Stroke Society
  • 23. Nov 2013, How Should we Use Antithrombotics in Cerebrovascular Disease?: Concerns of dual antiplatelet therapy at the Annual Meeting of the Korean Neurological Association.
  • 24. Oct 2013, Stroke Statistics in Korea during the 1st decade of the 21st Century: Epidemiology and Acute management at the 6th Korean-Japanese Stroke Conference
  • 25. Sep 2013, New anticoagulants: What is different? at the 2013 SNUH International Stroke Symposium
  • 26. Aug 2013, Stroke statistics in Korea: epidemiology at the 2013 Nordic Stroke Conference
  • 27. May 2013, Focused update of practice guideline of stroke at the Annual Meeting of the Korean Stroke Society.
  • 28. May 2013, Polyvascular disease in stroke patients at the Annual Meeting of the Korean Stroke Society.
  • 29. Mar 2013, Review of updated Korean Stroke Guidelines at the Annual Meeting of the Korean Society of Geriatric Neurology
  • 30. Nov 2012, Neurology Update I-Stroke at the Annual Meeting of the Korean Neurological Association.
  • 31. Nov 2012, Outcome of cardioembolic stroke at the International Conference Stroke Update
  • 32. Sep 2012, Long-term outcome of small vessel disease at the 2012 SNUH International Stroke Symposium
  • 33. Jun 2012, How to measure stroke severity and outcome at the 5th Asan Medical Center Stroke Symposium
  • 34. Apr 2012, Extended time window for intravenous thrombolysis at the Daejeon and Chungnam Regional Stroke Symposium of the Korean Stroke Society
  • 35. Apr 2012, Updates of Anticoagulation in Atrial Fibrillation at the 16th Korean Geriatric Medical Association
  • 36. Apr 2012, Extended time window for intravenous thrombolysis at the Daejeon-Chungnam Stroke and Cardiovascular Center Symposium
  • 37. Mar 2012, Longterm mortality and cardiovascular outcome in stroke patients at the Annual Meeting of the Korean Society of Cardiovascular Disease Prevention
  • 38. Nov 2011, Blood Pressure Management for Stroke and Cardiovascular disease prevention at the Stroke Center Symposium of Ilsan Paik Hospital Inje University
  • 39. Oct 2011, New Antithrombotics for Atrial Fibrillation: Updates and Debates at the 5th Korean-Japanese Stroke Conference
  • 40. May 2011, Combination of Clopidogrel and Aspirin in Patients with Atrial Fibrillation at the Annual Meeting of the Korean Stroke Society.
  • 41. May 2011, Emerging Antithrombotic Agents for Stroke Prevention at the Annual Meeting of the Korean Stroke Society.
  • 42. Apr 2011, Triflusal in the prevention of stroke and cardiovascular disease at the Annual Meeting of the Korean Neurological Association.
  • 43. Mar 2011, Development of Clinical Practice Guideline of Neurological Disorders at the Annual Meeting of the Korean Society of Geriatric Neurology
  • 44. Feb 2011, Stroke Outcome Analysis at the Educational Symposium of the Korean Stroke Society.
  • 45. Nov 2010, Stroke Update at the Annual Meeting of the Korean Neurological Association
  • 46. Sep 2010, Triflusal in the prevention of stroke and cardiovascular disease at the Pusan-Gyeongnam Regional Symposium of the Korean Stroke Society
  • 47. Jul 2010, Measuring and analysis of stroke outcome in stroke trials at the Annual Meeting of the Young-Honam Neurological Association
  • 48. Feb 2008, Acute Management of Stroke at the Stroke Update Symposium of the Korean Stroke Society
  • 49. Feb 2008, Development of stroke clinical practice guideline in Korea at the Annual Meeting of the Korean Society of Cerebrovascular Surgeons
  • 50. Nov 2007, Beyond intravenous tPA thrombolysis at the SNUH International Stroke Symposium:
  • 51. Jul 2007, Critical pathway for Acute Stroke at the Global Forum of Inje University Paik Medical Center
  • 52. Jan 2007, Challenging therapy in Acute Stroke at the Stroke Update Symposium of the Korean Stroke Society
  • 53. Sep 2006, Quality Indicators in Stroke Care in Korea at the 1st SNUH International Stroke Symposium:
  • 54. Jun 2006, Development of Quality Indicators in Stroke Care at the Annual Meeting of the Korean Stroke Society

  • Invited lectures at symposiums since 2012
  • 1. MAR 2017. Safe and Convenient NOAC, LIXIANA
  • 2. SEP 2016. What's new and better in anticoagulation therapy: A Perspective 5 years after ARISTOTLE
  • 3. AUG 2016. Statin for stroke: As good as its effect on Cardiovascular disease? Sparkling Symposium
  • 4. AUG 2016. Treatment of Hypertension in Stroke patients: DONGWHA LACOR SYMPOSIUM
  • 5. JUL 2016. Cilostazol in Neurology field
  • 6. MAY 2016. Effects of intensive BP lowering on stroke
  • 7. APR 2016. Redefining "VKA well controlled AF patients" in Korea
  • 8. FEB 2016. Optimizing strategies for the stroke prevention in CV risk patients
  • 9. Oct 2015, Endovascular therapy in acute ischemic stroke at the Dongwha Lacor Symposium
  • 10. Sep 2015, Emerge as Top Killers Worldwide: Coronary disease and Stroke at the My Rising Star Symposium
  • 11. Jul 2015, An appraisal of antiplatelet therapy for secondary stroke prevention of nocardioembolic stroke: P2Y12 inhibitors? At the PRAMIS symposium
  • 12. May 2015, State of Art: risk stratification of patients with atrial fibrillation at the CORSS symposium
  • 13. May 2015, Is there a future role for warfarin in stroke prevention for NVAF? At the Master Class symposium
  • 14. May 2015, Role of statin therapy in stroke prevention at the Discovery symposium
  • 15. May 2015, Stroke Prevention in Patients with Dyslipidemia: The Right Dose for the Right Patient at the REASON symposium
  • 16. Apr 2015, Exploring Relevance Between Blood Pressure Variability, monitoring hypertension and Stroke-Recent Research Update at the
  • 17. Mar 2015, Role of statin therapy in stroke prevention at the Discovery symposium
  • 18. Mar 2015, Dyslipidemia management for Stroke Prevention at the 16th My Life Your Decision Symposium
  • 19. Oct 2014, Dyslipidemia management with statins in acute ischemic stroke: Early benefit as well as long-term benefit? High intensity rather than moderate-to-low intensitiy? at the 1st Asian Pacific Stroke Summit
  • 20. Sep 2014, Statin Revisited: Evaluating High Intensity Statin's role in prevention of stroke at the TOP Symposium
  • 21. Sep 2014, Cons: Aortic plaque screening is not be a routine uation at the 2014 SNUH International Stroke Symposium
  • 22. Aug 2014, Evidence-based secondary stroke prevention from aspirin to new agents at the Asian Pacific Stroke Forum 2014
  • 23. Aug 2014, Thrombolysis in patients with Mild Stroke at the 2nd Stroke Expert Symposium
  • 24. Aug 2014, When should we start treatment? How low should we go? At the Olmetec 10-year Symposium
  • 25. Jul 2014, Dual antiplatelet therapy in stroke patients: Pros vs Cons, Sanofi Neuro Symposium
  • 26. Jul 2014, Statin Revisited: Evaluating High Intensity Statin's Role in Primary Prevention of Stroke, Pfizer The CARDS Symposium
  • 27. Jul 2014, Importance of improving Adherence, Pfizer SMART Symposium
  • 28. Apr 2014, Assessing and Managing CV Risk in Stroke Patients; ROLLERKOST, Pfizer OASIS Symposium
  • 29. Apr 2014, Optimal BP and Dyslipidemia management for stroke prevention: Target goal and adherence, 2014 SMART Concert
  • 30. Apr 2014, Turning to the next chapter for anticoagulants, ADVENT Forum
  • 31. Apr 2014, How to prevent and treat Cerebrovascular Event in patients with Polyvascular Disease, Good Morning Symposium
  • 32. Mar 2014, Management of acute ischemic stroke in AF patients, Focus SPAF symposium 2014
  • 33. Nov 2013, Guidelines for acute stroke management I: thrombolysis, Heart Brain Joint Symposium
  • 34. Nov 2013, Strategies in Lipid Management for Stroke Prevention, PCM WEB Symposium
  • 35. Nov 2013, Recent sub-analysis data from ARISTOTLE, All of the Above Apixaban symposium
  • 36. Nov 2013, Hypertension in Neurology, Boryung Symposium
  • 37. Aug 2013, Intravenous TPA as an adamant standard therapy in Acute Ischemic Stroke, Stroke Expert Symposium
  • 38. Aug 2013, Primary and Secondary Stroke Prevention: Evidences and Updates, SCALA e-Symposium
  • 39. Jul 2013, Polyvascular Disease in Stroke patients, Plavix Summer Symposium
  • 40. Jul 2013, The relationship between Knowledge, Attitude, Practice of Lipid Lowering Therapy in Stroke Patients (Rollerkost), TOP SYMPOSIUM
  • 41. May 2013, Acute management of Stroke, BI HERZIUM symposium
  • 42. Apr 2013, Established care of BP and Lipid control in Stroke, SMART Concert
  • 43. Apr 2013, What’s new in stroke guidelines for antithrombotic management in AF, Promising Role of Xarelto in Post-Warfarin Era Symposium
  • 44. Feb 2013, The importance of ischemic stroke: prevention and management, Pradaxa launch symposium
  • 45. Oct 2012, Dose-dependent BP variability effects, TRUST Symposium
  • 46. Oct 2012, Blood Pressure Management for Primary and Secondary Stroke Prevention, EXPLORE symposium
  • 47. Oct 2012, Management of Post Stroke Complication, CONNECT symposium
  • 48. Aug 2012, The importance of ischemic stroke: prevention and management, SPAF Academy symposium
  • 49. Aug 2012, Primary and Secondary Stroke Prevention: Evidences and Updates, SCALA e-Symposium
  • 50. Jul 2012, Long-term mortality and CV outcome after stroke, Plavix Summer Symposium
  • 51. Apr 2012, Hypertension Management in Stroke Patient, EXPLORE symposium
  • 52. Mar 2012, Stroke: What cardiologist should know about stroke, Focus SPAF symposium 2012
  • 53. Sep 2011, HT management for secondary stroke prevention, EXPLORE symposium
최고의 진료로 여러분의 건강을 지켜드립니다.